Management of Multiple Sclerosis Relapse

Rehabilitation and Support

Implement early rehabilitation interventions during the acute phase with gentle mobilization when medically stable, and adapt exercise intensity based on platelet counts, with exercise contraindicated if platelet counts are below 20 × 10⁹/l, as recommended by experts in the field of neurology 1
Provide respiratory support and exercises to optimize respiratory function, and manage spasticity through proper positioning, range-of-motion exercises, and medication administration as prescribed, following guidelines from reputable medical societies 1

Avoid supplementation with omega-3 fatty acids as they have not shown benefit in decreasing relapse severity, and consider supplementation with omega-6 fatty acids which may provide some benefit in decreasing relapse severity, according to the Clinical Nutrition society 2
Monitor nutritional intake and ensure adequate hydration during corticosteroid treatment, as advised by the Clinical Nutrition society 2
Do not rely solely on vitamin D supplementation to manage relapses, as studies have shown inconsistent results in reducing relapse rates, as reported by the Clinical Nutrition society 2, 5

Facilitate MRI studies as ordered to evaluate treatment response and disease activity, and understand that the presence of new T2 lesions on a 6-12 month follow-up scan does not necessarily reflect suboptimal response to treatment, as recommended by the Nature Reviews Neurology journal 4

Implement a four-phase rehabilitation approach, including Phase 1 (Pre-treatment): Enhance neuromuscular systems and respiratory function through pre-habilitation, Phase 2 (Weeks 0-4): Provide acute rehabilitation with gentle mobilization and optimization of respiratory function, Phase 3 (Weeks 8-12): Implement subacute rehabilitation with more intense physical therapy when medically stable, and Phase 4 (Weeks 12-26): Transition to community rehabilitation to promote independence and reintegration, as outlined by the Nature Reviews Neurology journal 1